Teal Health

About Teal Health

Teal Health is a San Francisco women's health company building accessible cervical cancer screening around the Teal Wand, the first FDA-authorized self-collection device for at-home HPV testing that does not require a speculum or clinic visit. Founded in 2020 by CEO Kara Egan and Dr Avnesh Thakor (Stanford), Teal pairs a brief telehealth consult and mailed kit with certified lab processing, secure results and follow-up care coordination, aiming to reach the large share of U.S. women who are overdue for screening because of appointment scarcity and discomfort with traditional Pap workflows. Clinical evidence cited by the company includes accuracy comparable to clinician-collected samples and strong patient preference scores; Teal reports thousands of women screened since FDA authorization in 2025, national guideline incorporation and partnerships with health systems, employers and payors. In September 2026 Teal raised a $22 million Series A led by .406 Ventures, with Emerson Collective (Yosemite), Forerunner, Serena Ventures and new investor MPower Partners, bringing total funding to about $45 million to expand payor, health-system and direct-purchase channels ahead of broad insurance coverage for self-collection expected in January 2027. Sources: Teal Health 22 Sep 2026.